Our non-invasive in vitro diagnostic medical device is based on a microfiltration system that capitalizes on the size of cancer cells, enabling efficient and unaltered capture of CTCs.
Designed to filter up to 6 mL of whole blood (2 x 3 mL), the CYTO kit guarantees optimal cell recovery under the best morphological integrity conditions.
For optimal results, CTC isolation must be performed within a maximum of 4 hours after collection.
The CYTO kit is compatible with mouse blood, allowing researchers to isolate murine circulating tumor cells and then directly observe their cytomorphology and perform more extensive downstream analyses.
This compatibility paves the way for the evaluation of new experimental treatments or therapeutic combinations in preclinical and pharmaceutical research.
Ref : Ye, F., Wechsler, J., Bouzidi, A. et al. Fast and efficient isolation of murine circulating tumor cells using screencell technology for pre-clinical analyzes. Sci Rep 14, 15019 (2024).
Get the most out of your ScreenCell® CTC isolation test with personalized support and expert guidance every step of the way.
Master ScreenCell® technology with hands-on training sessions.
Let our experts help you characterize circulating tumor cells with precision.
Benefit from personalized protocols adapted to your samples, goals, and research.
Our team is here to support you, from the first contact to the analysis.
You’ve come to the right place!
Fill in the fields below and we’ll take care of the rest.
Follow ScreenCell® on LinkedIn
